Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has received a consensus recommendation of “Buy” from the ...

Arcturus Therapeutics (ARCT) had a challenging fourth quarter, with revenue and earnings falling short of analyst ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) missed earnings with its latest annual results, disappointing overly-optimistic forecasters. Unfortunately, Arcturus Therapeutics Holdings delivered a ...

Canaccord analyst Whitney Ijem lowered the firm’s price target on Arcturus Therapeutics (ARCT) to $68 from $74 and keeps a Buy rating on the ...

Late on Thursday night and into the early hours of Friday, the full moon turned a beautiful reddish color as it drifted ...

Early crew members of the voyaging canoe Hokulea have gathered in Hawaii to celebrate the vessel's 50th birthday. The Hokulea ...

A ‘breakthrough approach’ for AI-powered automated line clearance in pharmaceutical manufacturing has been developed by ...

Technology has joined forces with industry leaders in machine vision, edge AI silicon and software – Balluff, Synaptics and ...

From malevolent computers to Arcturian shore leave, here are all the callbacks and references we spotted in these short clips ...

Hawaii’s American colonizers once banned the Hawaiian language in schools. Some Native Hawaiians tried to lighten their skin with lye. Many people believed Polynesian voyagers had simply lucked into ...

Learn more about whether Kymera Therapeutics, Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on AAII's ...